PAST SPEAKERS
Laura Matz
Chief Science & Technology Officer
Merck
Richard Bickerton
Chief System
Scientist Exscientia
Chris Gibson
CEO
Recursion
Fred Manby
CEO
Iambic Therapeutics
Craig Johnstone
Chief Operating Officer
Evotec
Ashwini Ghogare
Head of AI and Automation for Drug Discovery
Merck
Leaders shaping the future of drug discovery and beyond
KEYNOTES & ADVISORY
“Our very survival depends on our ability to stay awake, to adjust to new ideas, to remain vigilant and to face the challenge of change.” – Martin Luther King
The 16th Annual Drug Discovery and Development Summit brings together C-suite executives, pioneering thinkers, and leading academics committed to breaking free from traditional silos and driving impactful innovation. Our curated program is designed for leaders focused on strategy and advancing innovation in the pharmaceutical industry.
Generative AI and machine learning are revolutionising drug discovery by enabling faster identification of novel drug candidates, optimising development, and streamlining early-stage research. During the forum, we’ll explore how these technologies are reshaping the landscape and discuss strategies for overcoming challenges in Phase 3 clinical trials—the most time-consuming and costly stage—ultimately accelerating the delivery of life-saving therapies.
Werngard Czechtizky
Executive Director Head Medicinal Chemistry, Respiratory and Immunology at AstraZeneca
CONFIRMED SPEAKERS 2025
2025 PROGRAMME SNAPSHOT
KEY TOPICS
-
Revolutionising Healthcare Through Digital Innovation
-
Harnessing AI and Cell Therapy: Transforming Cancer and Age-Related Disease Treatments
-
Patient-first AI Drug Discovery
-
Case-Studies in AI-Driven Discovery
-
A Novel and Differentiated Approach to Targeted Protein Degradation
-
Rise and impact of Quantum Computing
FIRESIDE CHAT
-
How can we ensure that AI and data in combination with other key technologies lead to better and more patient-centric drug discovery?
-
What are the examples where it worked and can we reflect on why it worked out to be a successful case?
-
Holistic approaches (all data, all knowledge, plus algorithms)
WHY & MISSION
For over 15 years we have followed some of the most prominent CXO's, thought leaders and great minds who help drive and shape the future of Drug Discovery. But whats brings us together and away from our silos? The mission is to advance and to make an impact towards a purpose that is necessary. For the patients, we must do better.
WHY ATTEND
Engage in thought-provoking discussions on challenges and opportunities facing the drug discovery industry
Revolutionize R&D through AI & Machine Learning
In-Person only attendance of up to 200 decision-makers
Maximise your time by taking part in our exclusive pre-qualified one-to-one networking service
Hear exclusively from renowned leaders presenting on challenges when leveraging digital technologies, artificial intelligence, and machine learning in your innovation cycle
Leveraging AI to unblock drug discovery, drug repurposing and target validation
Explore the latest advancements, breakthroughs, and innovative approaches in the quest for new drugs and therapies
Uncover novel therapeutics targets, drug candidates, and innovative approaches that can drive the development of life-changing treatments
Journey of a CXO - witness in person The Why? The journey and destination of some of the most inspirational CXO’s in the industry
"Our mission remains the same - deliver accurate, reliable and compelling content that equates to business partnerships and collaborations that impact better patients outcomes."
INNOVATION SPOTLIGHT
-
Revolutionising healthcare through Digital Innovation by Merck
-
Case-Studies in AI-Driven Drug Discovery by Insilico Medicine
-
Meeting Pharma Challenges Head-on with AI Innovation by Aion Labs
-
AI/ML and Drug Discovery: ab in silico ad humanum by Novartis
WHY ATTEND
-
Closed door gatherings
-
Form strategic partnerships
-
Collaborate and transform ideas into meaningful outcomes, for the patients
VENDOR FOCUS
-
Digital transformation
-
Bioinformatics
-
Big data analytics and integration
-
End to end biologic workflows
-
AI-powered target identification
-
Integrated Drug Discovery
-
Out sourcing
-
CRO
-
Clinical Data Solutions
Type of Job Titles Attending:
-
CEO
-
CSO
-
CTO
-
CIO
-
EVP/SVP/VP
-
Director
Type of Companies Attending:
-
Pharmaceutical Organizations
-
Pharma and Research Institutions
-
Contract Development and Manufacturing Organizations
-
Government and Regulatory Agencies
-
Biotech Companies
-
Drug Discovery Solution Providers
-
Digital health and software providers
-
Logistics and supply chain companies
How CAN WE really use AI to advance drug discovery?
An invite only assembly of up to 200 leaders committed in making an impact.
It's people, their stories and this momentum that inspires purpose
THE NUMBERS
200+
Up to 200 decision-makers in person. Previous attendee demographics include 50% EMEA, 30% America and 20% ROW
20%
20% best-of-breed vendors supporting the drug discovery industry
06
Journey of CXO presentations. Six insightful, powerful and inspirational talks from CXOs in the industry
02
Exclusive in-person networking, over 2 days in Barcelona 2025
7+
Pre-scheduled and pre-qualified one-to-one meetings with delegates who can either influence or make a decision
90%
Over 90% of our attendance provided positive feedback. Please click here to see what our delegation has to say
